deutsch
Company
ScheBo® • Biotech AG is an innovative biotech company that is active in the fields of drug development and the development, production and marketing of diagnostics.
Continuous innovation, strong customer focus and creative problem solving have made ScheBo® • Biotech AG a worldwide leading manufacturer of unique products.
Netanyastrasse 3
35394 Giessen, Germany
Phone +49 -(0)641 -4996-0
Fax +49 -(0)641 -4996-77
eMail: schebo@schebo.com
www.schebo.de
» Contact form
P.O. Box 6359
Basingstoke, RG22 4WE, UK
Phone +44-(0)1256-477259
Fax +44-(0)1256-327889
eMail: i.smith@schebo.com
www.schebo.co.uk
(Registered office: 12 Semaphore Road, Guildford, GU1 3PS , England, Registered in England number: 3749167)
PMB 168
445 E Cheyenne Mountain Blvd., Suite C
Colorado Springs, CO 80906
Phone (254) 371-6978
Fax (719) 358-9100
eMail: info@schebousa.com
www.schebo.com
Continuous innovation, strong customer focus and creative problem solving have made ScheBo® • Biotech AG a worldwide leading manufacturer of unique products.
Head office:
ScheBo® • Biotech AGNetanyastrasse 3
35394 Giessen, Germany
Phone +49 -(0)641 -4996-0
Fax +49 -(0)641 -4996-77
eMail: schebo@schebo.com
www.schebo.de
» Contact form
UK and Republic of Ireland:
ScheBo® • Biotech UK LimitedP.O. Box 6359
Basingstoke, RG22 4WE, UK
Phone +44-(0)1256-477259
Fax +44-(0)1256-327889
eMail: i.smith@schebo.com
www.schebo.co.uk
(Registered office: 12 Semaphore Road, Guildford, GU1 3PS , England, Registered in England number: 3749167)
USA und Canada:
ScheBo® • Biotech USA Inc.PMB 168
445 E Cheyenne Mountain Blvd., Suite C
Colorado Springs, CO 80906
Phone (254) 371-6978
Fax (719) 358-9100
eMail: info@schebousa.com
www.schebo.com
A Decade of UK Success for Schebo Biotech
ScheBo® Biotech UK Limited, a leading provider of unique in-vitro diagnostic tests for the healthcare sector, has just celebrated its 10th Anniversary.
more...
more...
A superior alternative for PLT users: Faecal Pancreatic Elastase Test
Pfizer recommends this test in a letter it sent to pharmacists notifying them about the withdrawal of PLT.
more...
more...
Tumour M2-PK as a stool marker for colorectal cancer
Comparative analysis in a large sample of unselected older adults vs colorectal cancer patients.
more...
more...
Coeliac disease and pancreatic exocrine insufficiency
The data have shown that pancreatic insufficiency, demonstrated by low faecal pancreatic elastase-1 levels, is common in adult coeliac disease patients.
more...
more...
Colorectal cancer screening by non-invasive metabolic biomarker fecal tumor M2-PK
Fecal tumor M2-PK is an appropriately sensitve tool to pre-select those patients requiring colonoscopy for the further diagnostic confirmation or exclusion of colorectal cancer.
more...
more...